Finkelstein; Nina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Finkelstein; Nina.The latest application filed is for "solid states of aliskiren free base".

Company Profile

0.24.48

Finkelstein; Nina - Herzliya N/A IL
Finkelstein, Nina - Jerusalem IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Reference standard for characterization of rosuvastatin Grant 8,487,097 - Finkelstein July 16, 2	2013-07-16
Solid States Of Aliskiren Free Base App 20120095264 - Finkelstein; Nina ; et al.	2012-04-19
Solid state forms of aliskiren compounds Grant 8,148,576 - Finkelstein , et al. April 3, 2	2012-04-03
Polymorphic Forms Of Aliskiren Hemifumarate And Process For Preparation Thereof App 20120029083 - Finkelstein; Nina ; et al.	2012-02-02
Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates Grant 7,915,423 - Finkelstein , et al. March 29, 2	2011-03-29
Solid State Forms Of Aliskiren Compounds App 20100197793 - Finkelstein; Nina ; et al.	2010-08-05
Reference standard for characterization of rosuvastatin Grant 7,741,482 - Finkelstein June 22, 2	2010-06-22
Reference standard for characterization of rosuvastatin Grant 7,692,008 - Finkelstein April 6, 2	2010-04-06
Reference standard for characterization of rosuvastatin Grant 7,692,010 - Finkelstein April 6, 2	2010-04-06
Reference standard for characterization of rosuvastatin Grant 7,692,009 - Finkelstein April 6, 2	2010-04-06
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole Grant 7,683,177 - Braude , et al. March 23, 2	2010-03-23
Process for preparing forms of atorvastatin calcium substantially free of impurities Grant 7,674,923 - Finkelstein March 9, 2	2010-03-09
Crystalline Forms Of Sitagliptin Phosphate App 20100041885 - Perlman; Nurit ; et al.	2010-02-18
Methods For Preparing Eszopiclone Crystalline Form A, Substantially Pure Eszopiclone And Optically Enriched Eszopiclone App 20100029943 - MENDELOVICI; Marioara ; et al.	2010-02-04
Aliskiren Monofumarate And Processes For Preparation Thereof App 20100029774 - FINKELSTEIN; Nina ; et al.	2010-02-04
Process for preparing forms of atorvastatin calcium substantially free of impurities App 20100000302 - Finkelstein; Nina	2010-01-07
Method for the purification of lansoprazole Grant 7,622,588 - Singer , et al. November 24, 2	2009-11-24
Reference standard for characterization of rosuvastatin App 20090188305 - Finkelstein; Nina	2009-07-30
Crystalline clopidogrel hydrobromide and processes for preparation thereof App 20090187022 - Finkelstein; Nina ; et al.	2009-07-23
Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates Grant 7,507,829 - Finkelstein , et al. March 24, 2	2009-03-24
Racemization process of R-zopiclone App 20090018336 - Finkelstein; Nina ; et al.	2009-01-15
Crystalline clopidogrel hydrobromide and processes for preparation thereof App 20080306268 - Finkelstein; Nina ; et al.	2008-12-11
Crystalline clopidogrel hydrobromide and processes for preparation thereof App 20080300409 - Finkelstein; Nina ; et al.	2008-12-04
Methods for preparing eszopiclone App 20080287447 - Finkelstein; Nina ; et al.	2008-11-20
Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates App 20080132707 - Finkelstein; Nina ; et al.	2008-06-05
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole App 20080004319 - Braude; Viviana ; et al.	2008-01-03
Methods For Preparing Eszopiclone Crystalline Form A, Substantially Pure Eszopiclone And Optically Enriched Eszopiclone App 20070270590 - MENDELOVICI; Marioara ; et al.	2007-11-22
Reference standard for characterization of rosuvastatin App 20070255059 - Finkelstein; Nina	2007-11-01
Reference for characterization of rosuvastatin App 20070249831 - Finkelstein; Nina	2007-10-25
Reference standard for characterization of rosuvastatin App 20070249830 - Finkelstein; Nina	2007-10-25
Reference standard for characterization of rosuvastatin App 20070244321 - Finkelstein; Nina	2007-10-18
Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard App 20070197529 - Braude; Viviana ; et al.	2007-08-23
Crystalline and amorphous forms of telithromycin App 20070167382 - Finkelstein; Nina ; et al.	2007-07-19
Reference standard for characterization of rosuvastatin Grant 7,244,844 - Finkelstein July 17, 2	2007-07-17
Crystalline clopidogrel hydrobromide and processes for preparation thereof App 20060154957 - Finkelstein; Nina ; et al.	2006-07-13
Process for preparing forms of atorvastatin calcium substantially free of impurities App 20060142592 - Finkelstein; Nina	2006-06-29
Substantially pure cilostazol and processes for making same Grant 7,067,669 - Mendelovici , et al. June 27, 2	2006-06-27
Substantially pure cilostazol and processes for making same Grant 7,064,208 - Mendelovici , et al. June 20, 2	2006-06-20
Method for the purification of lansoprazole Grant 7,060,837 - Singer , et al. June 13, 2	2006-06-13
Substantially pure cilostazol and processing for making same Grant 7,060,833 - Mendelovici , et al. June 13, 2	2006-06-13
Substantially pure cilostazol and processes for making same App 20060094756 - Mendelovici; Marioara ; et al.	2006-05-04
Substantially pure cilostazol and processes for making same App 20060094757 - Mendelovici; Marioara ; et al.	2006-05-04
Method for the purification of lansoprazole Grant 7,022,859 - Singer , et al. April 4, 2	2006-04-04
Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof Grant 6,963,008 - Finkelstein , et al. November 8, 2	2005-11-08
Reference standard for characterization of rosuvastatin App 20050187234 - Finkelstein, Nina	2005-08-25
Method for the purification of lansoprazole App 20050165059 - Singer, Claude ; et al.	2005-07-28
Method for the purification of lansoprazole App 20050165061 - Singer, Claude ; et al.	2005-07-28
Method for the purification of lansoprazole App 20050165060 - Singer, Claude ; et al.	2005-07-28
Method for the purification of lansoprazole Grant 6,909,004 - Singer , et al. June 21, 2	2005-06-21
Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole App 20050075370 - Braude, Viviana ; et al.	2005-04-07
Substantially pure cilostazol and processing for making same App 20050065343 - Mendelovici, Marioara ; et al.	2005-03-24
Substantially pure cilostazol and processes for making same Grant 6,825,214 - Mendelovici , et al. November 30, 2	2004-11-30
Crystalline and amorphous solids of pantoprazole and processes for their preparation App 20040235904 - Finkelstein, Nina ; et al.	2004-11-25
Method for the purification of lansoprazole App 20040192923 - Singer, Claude ; et al.	2004-09-30
Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates App 20040177804 - Finkelstein, Nina ; et al.	2004-09-16
Novel synthesis and crystallization of peperazine ring-containing compounds App 20040176591 - Singer, Claude ; et al.	2004-09-09
Preparation of N-methylparoxetine and related intermediate compounds Grant 6,777,554 - Finkelstein August 17, 2	2004-08-17
Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof App 20040158098 - Finkelstein, Nina ; et al.	2004-08-12
Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles App 20040138466 - Avrutov, Ilya ; et al.	2004-07-15
Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof Grant 6,696,601 - Finkelstein , et al. February 24, 2	2004-02-24
Lansoprazole polymorphs and processes for preparation thereof App 20040010151 - Finkelstein, Nina ; et al.	2004-01-15
Substantially pure cilostazol and processes for making same App 20030166937 - Mendelovici, Marioara ; et al.	2003-09-04
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030135043 - Singer, Claude ; et al.	2003-07-17
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030120068 - Singer, Claude ; et al.	2003-06-26
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030088094 - Singer, Claude ; et al.	2003-05-08
Novel synthesis and crystallization of piperazine ring-containing compounds App 20030069417 - Singer, Claude ; et al.	2003-04-10
Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof App 20030065214 - Finkelstein, Nina ; et al.	2003-04-03
Preparation of N-methylparoxetine and related intermediate compounds App 20020151567 - Finkelstein, Nina	2002-10-17
Processes for preparing cilostazol App 20020099213 - Mendelovici, Marioara ; et al.	2002-07-25
Novel synthesis and crystallization of piperazine ring-containing compounds App 20010051718 - Singer, Claude ; et al.	2001-12-13
Polyamine derivatives of 1-aminoindan Grant 5,646,188 - Gilad , et al. July 8, 1	1997-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.